These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11704757)
21. Topical efinaconazole: A sequential combination therapy with oral terbinafine for refractory tinea unguium. Noguchi H; Kubo M; Kashiwada-Nakamura K; Makino K; Aoi J; Fukushima S J Dermatol; 2021 Sep; 48(9):1401-1404. PubMed ID: 34028842 [TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial. Yadav P; Singal A; Pandhi D; Das S Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080 [TBL] [Abstract][Full Text] [Related]
23. Intermittent therapy with terbinafine and nail abrasion for dermatophyte toe onychomycosis: a pilot study. Succi IB; Bernardes-Engemann AR; Orofino-Costa R Mycoses; 2013 May; 56(3):327-32. PubMed ID: 23294342 [TBL] [Abstract][Full Text] [Related]
24. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases. Ranawaka RR; Nagahawatte A; Gunasekara TA Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159 [TBL] [Abstract][Full Text] [Related]
25. The efficacy of fractional carbon dioxide (CO Shi J; Li J; Huang H; Permatasari F; Liu J; Xu Y; Wu D; Zhou BR; Luo D J Cosmet Laser Ther; 2017 Oct; 19(6):353-359. PubMed ID: 28557542 [TBL] [Abstract][Full Text] [Related]
26. A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis. Havu V; Heikkilä H; Kuokkanen K; Nuutinen M; Rantanen T; Saari S; Stubb S; Suhonen R; Turjanmaa K Br J Dermatol; 2000 Jan; 142(1):97-102. PubMed ID: 10651701 [TBL] [Abstract][Full Text] [Related]
27. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776 [TBL] [Abstract][Full Text] [Related]
28. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. Gupta AK J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137 [TBL] [Abstract][Full Text] [Related]
29. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Zaias N; Rebell G Arch Dermatol; 2004 Jun; 140(6):691-5. PubMed ID: 15210459 [TBL] [Abstract][Full Text] [Related]
30. Terbinafine: a review of its use in onychomycosis in adults. Darkes MJ; Scott LJ; Goa KL Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372 [TBL] [Abstract][Full Text] [Related]
31. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group. Bräutigam M; Nolting S; Schopf RE; Weidinger G BMJ; 1995 Oct; 311(7010):919-22. PubMed ID: 7580551 [TBL] [Abstract][Full Text] [Related]
32. Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study. Gupta AK; J Drugs Dermatol; 2005; 4(4):481-5. PubMed ID: 16004022 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations. Pollak R; Billstein SA J Am Podiatr Med Assoc; 2001 Mar; 91(3):127-31. PubMed ID: 11266494 [TBL] [Abstract][Full Text] [Related]
34. An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis (.). Shemer A; Gupta AK; Amichai B; Farhi R; Baran R; Daniel CR; Daigle D; Foley KA J Dermatolog Treat; 2016 Oct; 27(5):480-3. PubMed ID: 27032812 [TBL] [Abstract][Full Text] [Related]
35. Nail incorporation kinetics of terbinafine in onychomycosis patients. Schatz F; Bräutigam M; Dobrowolski E; Effendy I; Haberl H; Mensing H; Weidinger G; Stütz A Clin Exp Dermatol; 1995 Sep; 20(5):377-83. PubMed ID: 8593713 [TBL] [Abstract][Full Text] [Related]
36. Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis. Takiuchi I; Morishita N; Hamaguchi T; Ninomiya J; Higuchi R Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):285-9. PubMed ID: 16282972 [TBL] [Abstract][Full Text] [Related]